The Impact and Long-Term Potential of Olaratumab in Soft Tissue Sarcoma
2 Mga view
• 07/18/23
0
0
I-embed
administrator
Mga subscriber
Symantha Melemed, PhD, global product team lead, Oncology Business Unit, Eli Lilly & Company, discusses the impact of the FDA approval of olaratumab (Lartruvo) and its long-term potential in the field of sarcoma.
Magpakita ng higit pa
Mga Komento sa Facebook
SORT BY-
Mga Nangungunang Komento
-
Pinakabagong komento